1. Home
  2. CALC vs OMCC Comparison

CALC vs OMCC Comparison

Compare CALC & OMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • OMCC
  • Stock Information
  • Founded
  • CALC 2011
  • OMCC 1985
  • Country
  • CALC United States
  • OMCC United States
  • Employees
  • CALC N/A
  • OMCC N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • OMCC
  • Sector
  • CALC Health Care
  • OMCC
  • Exchange
  • CALC Nasdaq
  • OMCC NYSE
  • Market Cap
  • CALC 20.9M
  • OMCC 39.3M
  • IPO Year
  • CALC N/A
  • OMCC N/A
  • Fundamental
  • Price
  • CALC $2.07
  • OMCC $5.05
  • Analyst Decision
  • CALC Strong Buy
  • OMCC
  • Analyst Count
  • CALC 3
  • OMCC 0
  • Target Price
  • CALC $16.33
  • OMCC N/A
  • AVG Volume (30 Days)
  • CALC 28.2K
  • OMCC 2.2K
  • Earning Date
  • CALC 05-20-2025
  • OMCC 06-30-2025
  • Dividend Yield
  • CALC N/A
  • OMCC N/A
  • EPS Growth
  • CALC N/A
  • OMCC N/A
  • EPS
  • CALC N/A
  • OMCC N/A
  • Revenue
  • CALC N/A
  • OMCC $25,153,000.00
  • Revenue This Year
  • CALC N/A
  • OMCC N/A
  • Revenue Next Year
  • CALC N/A
  • OMCC N/A
  • P/E Ratio
  • CALC N/A
  • OMCC N/A
  • Revenue Growth
  • CALC N/A
  • OMCC N/A
  • 52 Week Low
  • CALC $1.43
  • OMCC $4.21
  • 52 Week High
  • CALC $6.02
  • OMCC $7.01
  • Technical
  • Relative Strength Index (RSI)
  • CALC 69.21
  • OMCC N/A
  • Support Level
  • CALC $1.52
  • OMCC N/A
  • Resistance Level
  • CALC $2.15
  • OMCC N/A
  • Average True Range (ATR)
  • CALC 0.13
  • OMCC 0.00
  • MACD
  • CALC 0.08
  • OMCC 0.00
  • Stochastic Oscillator
  • CALC 88.89
  • OMCC 0.00

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About OMCC OLD MARKET CAPITAL CORPORATION

Old Market Capital Corp formerly Nicholas Financial Inc is a specialized consumer finance company. It is engaged in acquiring and servicing automobile finance installment contracts for purchases of used and new automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance-related products. The majority of its revenue comes from Interest and fee income.

Share on Social Networks: